Cancer doctors optimistic over success of immunotherapy

Tcell
T-cells attack a cancer cell. [Credit:NIH]

Harnessing the immune system to fight cancer, long a medical dream, is becoming a reality. Remarkable stories of tumors melting away and terminal illnesses going into remissions…— backed by solid data — have led to an explosion of interest and billions of dollars of investments in the rapidly growing field of immunotherapy.

All this has brought new optimism to cancer doctors — a sense that they have begun tapping into a force of nature, the medical equivalent of splitting the atom.

Hundreds of clinical trials involving immunotherapy…are underway for nearly every type of cancer. “People are asking, waiting, pleading to get into these trials,” said Dr. Arlene Siefker-Radtke[.]

If there is a potential downside to the advances, Dr. [Matthew] Hellmann said, it is that the buzz about immunotherapy has led some patients to think chemotherapy is passé.

“Immunotherapy represents a hugely important new tool, but chemotherapy can work too and has been the backbone of the way we’ve treated patients with…cancer,” he said. “Immunotherapy is not a replacement for that. It’s a new weapon.”

The GLP aggregated and excerpted this blog/article to reflect the diversity of news, opinion and analysis. Read full, original post: Harnessing the Immune System to Fight Cancer

Related Articles

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Does glyphosate—the world's most heavily-used herbicide—pose serious harm to humans? Is it carcinogenic? Those issues are of both legal and ...

Most Popular

ChatGPT-Image-Aug-4-2026-10_15_14-AM
Viewpoint—A hard look at the Fauci diaries: Do they change what we know about COVID’s origins?
ChatGPT-Image-Mar-10-2026-01_39_01-PM
Viewpoint—“Miracle molecule” debunked: Why acemannan supplements don’t work
Picture1
Hiroshima at 81: America’s new nuclear bomb, a buried Iranian target, and a question no one wants to ask
ChatGPT-Image-Aug-4-2026-12_42_58-PM
Viewpoint: Fact-checking CNN interview with RFK, Jr. underscores the depth of his disinformation delusions
ChatGPT-Image-Jul-17-2026-09_50_27-AM
Viewpoint: How disease tracking and prevention has cratered under the Kennedy-Trump administration
ChatGPT-Image-Aug-4-2026-07_52_00-PM
No liability for scientific due diligence: California Supreme Court rejects bizarre lawsuit faulting Gilead for fully evaluating HIV drug before release
ChatGPT-Image-Aug-4-2026-09_31_50-AM-2
Viewpoint: Could the U.S. become dependent on China to develop critical new genetic and drug therapies?
png livestock cow cattle a
Consumer skepticism about gene-edited milk is neither fixed nor particularly high—and falls even more if it’s priced lower
ChatGPT-Image-Aug-4-2026-02_05_46-PM
Does Congress have the guts to successfully challenge Trump’s politicization of science funding?
Screenshot-2026-07-17-at-1.34.59-PM
Poll: Vaccine hesitancy soars when patients distrust health providers and turn to social media
Screenshot-2026-07-31-at-10.52.03-AM
Love sweets and fatty foods? You can blame your genes, but there are ways to quell the obsessions
ChatGPT Image Jul 29, 2026, 09_08_15 AM 2
The retreat of environmental extremism: Why activist NGOs are losing favor
glp menu logo outlined

Get news on human & agricultural genetics and biotechnology delivered to your inbox.